Covestor’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2K | Sell |
205
-51
| -20% | -$498 | ﹤0.01% | 1822 |
|
|
2025
Q1 | $2K | Buy |
256
+239
| +1,406% | +$1.87K | ﹤0.01% | 1814 |
|
|
2024
Q4 | $0 | Buy |
17
+1
| +6% | – | ﹤0.01% | 2232 |
|
|
2024
Q3 | $0 | Sell |
16
-1
| -6% | – | ﹤0.01% | 2214 |
|
|
2024
Q2 | $0 | Hold |
17
| – | – | ﹤0.01% | 2243 |
|
|
2024
Q1 | $0 | Sell |
17
-2
| -11% | – | ﹤0.01% | 2237 |
|
|
2023
Q4 | $0 | Buy |
19
+3
| +19% | – | ﹤0.01% | 2147 |
|
|
2023
Q3 | $0 | Sell |
16
-199
| -93% | – | ﹤0.01% | 2117 |
|
|
2023
Q2 | $2K | Sell |
215
-43
| -17% | -$400 | ﹤0.01% | 1798 |
|
|
2023
Q1 | $2K | Sell |
258
-2
| -0.8% | -$16 | ﹤0.01% | 1735 |
|
|
2022
Q4 | $3K | Buy |
260
+115
| +79% | +$1.33K | ﹤0.01% | 1672 |
|
|
2022
Q3 | $2K | Sell |
145
-4
| -3% | -$55 | ﹤0.01% | 1676 |
|
|
2022
Q2 | $2K | Buy |
149
+1
| +0.7% | +$13 | ﹤0.01% | 1575 |
|
|
2022
Q1 | $2K | Sell |
148
-7
| -5% | -$95 | ﹤0.01% | 1645 |
|
|
2021
Q4 | $2K | Buy |
+155
| New | +$2K | ﹤0.01% | 1519 |
|